Core Viewpoint - The domestic medical device industry in China is accelerating its international expansion, supported by favorable policies and innovations in medical devices, leading to significant market activity and investment inflows [1][2]. Group 1: Market Performance - The largest medical device ETF in the market, $医疗器械ETF(159883)$, saw an increase of over 2%, with fund subscriptions exceeding 100 million shares and a growth of 1.48 billion shares in the past week, marking five consecutive days of net subscriptions [1]. - Notable stock performances include 一寨失7 with a rise of 19.98%, 赛诺医疗 up by 15.86%, and 中红医疗 increasing by 12.05% [1]. Group 2: Policy Support - Recent policies from seven ministries, including the Ministry of Industry and Information Technology, emphasize support for innovative medical devices, particularly in the brain-computer interface sector, aiming for significant advancements by 2027 and 2030 [2][3]. - The National Medical Insurance Administration has held discussions focused on supporting innovative medical devices, indicating a strong policy backing for the sector [2]. Group 3: Industry Growth - The Chinese medical device market is projected to exceed 1,032.8 billion yuan in 2023, maintaining its position as the second-largest globally, driven by policy support, aging population, and technological innovations [4]. - The industry is experiencing a transformation with the deepening of centralized procurement, reshaping market dynamics and promoting the development of domestic high-end medical devices [4].